Trial · NCT01019694
Outcomes39
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 39
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 48 | 48 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | 3 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 12 | 12 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 24 | 24 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Performance Domain Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 36 | 36 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 0 | 0 weeks | Treated Set is defined as all patients who were randomized and received study drug | units on a scale | MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 3 | 3 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 12 | 12 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 24 | 24 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 36 | 36 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Overall Satisfaction Score From the Patient Satisfaction and Preference Questionnaire (PASAPQ) at Week 48 | 48 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 0 | 0 weeks | Treated Set is defined as all patients who were randomized and received study drug | units on a scale | MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 3 | 3 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 12 | 12 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 24 | 24 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 36 | 36 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Clinical COPD Questionnaire (CCQ) Symptom Domain Score at Week 48 | 48 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Physician's Global Evaluation at Week 0 | 0 weeks | Treated Set is defined as all patients who were randomized and received study drug | units on a scale | MEAN |
| SECONDARY | Physician's Global Evaluation at Week 3 | 3 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Physician's Global Evaluation at Week 12 | 12 weeks | Treated Set is defined as all patients who were randomized and received study drug | unit on a scale | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01019694/outcomes